{"id":50795,"name":"COALITION FOR INNOVATIVE LABORATORY TESTING, INC.","slug":"coalition-for-innovative-laboratory-testing-inc","state":"MD","country":"United States of America","description":"Advocate for legislation and regulations impacting clinical laboratory tests","totalSpending":102000,"filings":16,"yearlySpending":[{"year":2022,"income":93000},{"year":2023,"income":9000},{"year":2024,"income":0},{"year":2025,"income":0}],"issues":["MED"],"firms":["COMPASS GOVERNMENT RELATIONS PARTNERS, LLC"],"lobbyists":["HANNAH GARAGIOLA","MORGAN MILLS","ROBERT GARAGIOLA"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Food & Drug Administration (FDA)","Office of Management & Budget (OMB)","Small Business Administration (SBA)"],"sampleDescriptions":["VALID Act of 2021 (H.R. 4128/ S. 2209; Provisions that negatively impact Clinical Laboratory Improvement Amendments (CLIA)- approved laboratory businesses","VALID Act of 2021 (H.R.4128/S.2209; Provisions that negatively impact Clinical Laboratory Improvement Amendments (CLIA)-approved laboratory businesses","VALID Act of 2021 (H.R.4128/S.2209; Provisions that negatively impact Clinical Laboratory Improvement Amendments (CLIA)-approved laboratory businesses","VALID Act of 2021 (H.R.4128/S.2209; Provisions that negatively impact Clinical Laboratory Improvement Amendments (CLIA)-approved laboratory businesses FDASLA (S.4348); Provisions that negatively impac","VALID Act of 2021 (H.R.4128/S.2209; Provisions that negatively impact Clinical Laboratory Improvement Amendments (CLIA)-approved laboratory businesses FDASLA (S.4348); Provisions that negatively impac"],"years":[2022,2023,2024,2025]}